CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C00704 | BRD-A28318179 | aminomethyltransferase | -- | -- | -- | Details |
C00705 | BRD-A28412351 | BRD-A28412351 | -- | -- | -- | Details |
C00706 | BRD-A28422058 | L-689560 | -- | -- | -- | Details |
C00707 | BRD-A28422330 | ML-141 | -- | -- | -- | Details |
C00708 | BRD-A28467416 | PKI-179 | MTOR | MTOR inhibitor; PI3K inhibitor | -- | Details |
C00709 | BRD-A28545468 | selegiline | MAOA; MAOB | Monoamine oxidase inhibitor | -- | Details |
C00710 | BRD-A28746609 | paclitaxel | TUBB; NR1I2 | Tubulin inhibitor | -- | Details |
C00711 | BRD-A28787076 | inosine | -- | -- | -- | Details |
C00712 | BRD-A28856712 | tetryzoline | -- | -- | tetrahydrozoline | Details |
C00713 | BRD-A28887267 | proxyphylline | -- | -- | -- | Details |
C00714 | BRD-A28932952 | BRD-A28932952 | -- | -- | -- | Details |
C00715 | BRD-A28940325 | trichlormethiazide | SLC12A1 | Chloride channel antagonist | -- | Details |
C00716 | BRD-A28958257 | centpropazine | -- | -- | -- | Details |
C00717 | BRD-A28970875 | puromycin | -- | -- | -- | Details |
C00718 | BRD-A29009894 | AZD-1480 | JAK1; JAK2 | JAK inhibitor | -- | Details |
C00719 | BRD-A29082194 | gitoxigenin | ATP1A1 | ATPase inhibitor | -- | Details |
C00720 | BRD-A29119732 | BRD-A29119732 | -- | -- | -- | Details |
C00721 | BRD-A29260609 | acebutolol | ADRB1 | Adrenergic receptor antagonist | -- | Details |
C00722 | BRD-A29289453 | PCA-4248 | PTAFR | Platelet activating factor receptor antagonist | -- | Details |
C00723 | BRD-A29322418 | potassium-canrenoate | NR3C2 | Mineralocorticoid receptor antagonist | -- | Details |
C00724 | BRD-A29342309 | BRD-A29342309 | -- | -- | -- | Details |
C00725 | BRD-A29349577 | dropropizine | -- | -- | -- | Details |
C00726 | BRD-A29371732 | BRD-A29371732 | -- | -- | -- | Details |
C00727 | BRD-A29426959 | carbinoxamine | HRH1 | Histamine receptor antagonist; L-type calcium channel blocker | -- | Details |
C00728 | BRD-A29437505 | RWJ-21757 | TLR7 | TLR agonist | -- | Details |
C00729 | BRD-A29485665 | bicalutamide | AR | Androgen receptor antagonist | -- | Details |
C00730 | BRD-A29520968 | acifran | -- | -- | -- | Details |
C00731 | BRD-A29578214 | BRD-A29578214 | -- | -- | -- | Details |
C00732 | BRD-A29623586 | anisodamine | ADRA1A | Lipid peroxidase inhibitor | -- | Details |
C00733 | BRD-A29644307 | nomifensine | SLC6A2; SLC6A3 | Dopamine uptake inhibitor; Noradrenaline uptake inhibitor | -- | Details |
C00734 | BRD-A29721261 | BRD-A29721261 | -- | -- | -- | Details |
C00735 | BRD-A29731977 | BRD-A29731977 | -- | -- | 17-hydroxyprogesterone-caproate | Details |
C00736 | BRD-A29734477 | BRD-A29734477 | -- | -- | -- | Details |
C00737 | BRD-A29734509 | disopyramide | SCN5A | Sodium channel blocker | -- | Details |
C00738 | BRD-A29800834 | dimethoxane | -- | -- | -- | Details |
C00739 | BRD-A29844814 | ABT-202 | -- | -- | -- | Details |
C00740 | BRD-A29854054 | lorglumide | CCKAR; CCKBR | CCK receptor antagonist | -- | Details |
C00741 | BRD-A29887287 | chlordane | -- | -- | -- | Details |
C00742 | BRD-A29901043 | KIN001-127 | ITK | ITK inhibitor | KIN-001-127 | Details |
C00743 | BRD-A29957585 | BRD-A29957585 | -- | -- | -- | Details |
C00744 | BRD-A30051119 | amikacin | -- | -- | -- | Details |
C00745 | BRD-A30083233 | BRD-A30083233 | -- | -- | -- | Details |
C00746 | BRD-A30142024 | dithiothreitol | -- | -- | -- | Details |
C00747 | BRD-A30193965 | amphotericin | -- | -- | -- | Details |
C00748 | BRD-A30205217 | ethotoin | SCN5A | Hydantoin antiepileptic | -- | Details |
C00749 | BRD-A30369394 | BRD-A30369394 | -- | -- | -- | Details |
C00750 | BRD-A30395175 | BRD-A30395175 | -- | -- | -- | Details |
C00751 | BRD-A30435184 | metergoline | HTR1A; HTR2A | Serotonin receptor antagonist; Dopamine receptor agonist | -- | Details |
C00752 | BRD-A30437061 | camptothecin | TOP1 | Topoisomerase inhibitor | -- | Details |
C00753 | BRD-A30455275 | BRD-A30455275 | -- | -- | -- | Details |
C00754 | BRD-A30547447 | BRD-A30547447 | -- | -- | -- | Details |
C00755 | BRD-A30582499 | tiletamine | -- | -- | -- | Details |
C00756 | BRD-A30590053 | MR-16728 | -- | -- | -- | Details |
C00757 | BRD-A30612536 | BRD-A30612536 | -- | -- | -- | Details |
C00758 | BRD-A30655177 | LFM-A13 | BTK | BTK inhibitor | -- | Details |
C00759 | BRD-A30693873 | diperodon | -- | -- | -- | Details |
C00760 | BRD-A30717181 | triamcinolone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
C00761 | BRD-A30758703 | BRD-A30758703 | -- | -- | -- | Details |
C00762 | BRD-A30815329 | felodipine | NR3C2; CACNA1C; CACNA1D; CACNA1S | Calcium channel blocker | -- | Details |
C00763 | BRD-A30856524 | BRD-A30856524 | -- | -- | -- | Details |
C00764 | BRD-A30962679 | BRD-A30962679 | -- | -- | -- | Details |
C00765 | BRD-A30977374 | nifedipine | CACNA1C; CACNA1D; CACNA1F; CACNA1S; CACNA2D1 | Calcium channel blocker | -- | Details |
C00766 | BRD-A30984645 | GDC-0834 | BTK | BTK inhibitor | -- | Details |
C00767 | BRD-A31007383 | SDZ-WAG-994 | ADORA1 | Adenosine receptor agonist | -- | Details |
C00768 | BRD-A31009033 | dipropylene-glycol | -- | -- | -- | Details |
C00769 | BRD-A31095847 | mozavaptan | AVPR1A; AVPR1B; AVPR2 | Vasopressin receptor antagonist | -- | Details |
C00770 | BRD-A31107743 | brefeldin-a | -- | -- | -- | Details |
C00771 | BRD-A31158127 | calcipotriol | VDR | Vitamin D receptor agonist | -- | Details |
C00772 | BRD-A31159102 | fluoxetine | SLC6A4 | Selective serotonin reuptake inhibitor | -- | Details |
C00773 | BRD-A31180007 | BRD-A31180007 | -- | -- | -- | Details |
C00774 | BRD-A31195449 | TCB2 | HTR2A | Serotonin receptor agonist | TCB-2 | Details |
C00775 | BRD-A31204924 | mitotane | CYP11A1; CYP11B1 | Anti-neoplastic agent | -- | Details |
C00776 | BRD-A31227688 | kynuramine | -- | -- | -- | Details |
C00777 | BRD-A31312900 | montelukast | CYSLTR1 | Leukotriene receptor antagonist | -- | Details |
C00778 | BRD-A31374339 | fludarabine | RRM1 | DNA synthesis inhibitor | -- | Details |
C00779 | BRD-A31429689 | BRD-A31429689 | -- | -- | -- | Details |
C00780 | BRD-A31521121 | methocarbamol | CA1 | Muscle relaxant | -- | Details |
C00781 | BRD-A31575449 | CGP-20712 | ADRB1 | Adrenergic receptor antagonist | -- | Details |
C00782 | BRD-A31576716 | BRD-A31576716 | -- | -- | -- | Details |
C00783 | BRD-A31602150 | BRD-A31602150 | -- | -- | -- | Details |
C00784 | BRD-A31800922 | procyclidine | -- | -- | -- | Details |
C00785 | BRD-A31801025 | formestane | CYP19A1 | Aromatase inhibitor | -- | Details |
C00786 | BRD-A31811760 | miltefosine | -- | -- | -- | Details |
C00787 | BRD-A31836915 | cyanocobalamin | MMUT | Vitamin B; Methylmalonyl CoA mutase stimulant | -- | Details |
C00788 | BRD-A31916785 | BRD-A31916785 | -- | -- | -- | Details |
C00789 | BRD-A31946439 | BRD-A31946439 | -- | -- | -- | Details |
C00790 | BRD-A31962514 | BRD-A31962514 | -- | -- | -- | Details |
C00791 | BRD-A32018906 | BRD-A32018906 | -- | -- | -- | Details |
C00792 | BRD-A32065788 | BRD-A32065788 | -- | -- | -- | Details |
C00793 | BRD-A32128687 | BRD-A32128687 | -- | -- | -- | Details |
C00794 | BRD-A32161980 | carbetocin | OXTR | Oxytocin receptor agonist | -- | Details |
C00795 | BRD-A32164164 | methyllycaconitine | CHRNA7 | Acetylcholine receptor antagonist | -- | Details |
C00796 | BRD-A32172948 | methiopril | ACE | Angiotensin converting enzyme inhibitor | -- | Details |
C00797 | BRD-A32213225 | BRD-A32213225 | -- | -- | -- | Details |
C00798 | BRD-A32214171 | BRD-A32214171 | -- | -- | -- | Details |
C00799 | BRD-A32241587 | BRD-A32241587 | -- | -- | -- | Details |
C00800 | BRD-A32269193 | VGX-1027 | TLR4 | Tumor necrosis factor receptor antagonist | -- | Details |
C00801 | BRD-A32349859 | methyl-angolensate | HTR2B | Apoptosis inhibitor | -- | Details |
C00802 | BRD-A32440707 | BRD-A32440707 | -- | -- | -- | Details |
C00803 | BRD-A32444030 | BIIE-0246 | -- | -- | -- | Details |